Clinical Trial Detail

NCT ID NCT01251575
Title Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Fred Hutchinson Cancer Research Center
Indications

acute myeloid leukemia

acute lymphocytic leukemia

multiple myeloma

Hodgkin's lymphoma

chronic myeloid leukemia

diffuse large B-cell lymphoma

mantle cell lymphoma

chronic lymphocytic leukemia

bone marrow cancer

non-Hodgkin lymphoma

Therapies

Fludarabine

Cyclosporine + Mycophenolate mofetil + Sirolimus

Age Groups: adult

No variant requirements are available.